Metrex Research, LLC Awarded High Level Disinfectant ASCEND® Agreement With Premier
ORANGE, Calif., June 4, 2020 (Newswire.com) - Metrex Research, LLC has been awarded a group purchasing agreement for High Level Disinfectant and Intermediate Level Disinfectant Wipes with Premier. Effective May 1, 2020, these new agreements allow Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for CaviWipes™, CaviCide™, MetriCide™ OPA Plus Solution (MOPA), and Glutaraldehydes.
“We are honored that Premier has chosen to award Metrex both a National Agreement as well as an ASCEND contract on Premier’s committed program. These contracts allow healthcare facilities and providers access to a complete portfolio of Infection Prevention products that are required in today’s market to fight the spread of emerging viruses and pathogens,” said Dr. Yatao Liu, Metrex General Manager. “Metrex Research has been dedicated to meaningful innovation, high-quality manufacturing made in the U.S., scientific evidence-based education, and superior customer service for over 35 years. Metrex is proud to serve over 80 countries to help fight the COVID-19 pandemic. We are committed to helping Premier members take full advantage of our offerings, from products to professional training. This agreement between Metrex and Premier members will help accomplish Metrex’ mission to create a world without preventable healthcare-associated infections.”
Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,000 U.S. hospitals and 175,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost.
ABOUT SUPPLIER
Metrex Research, LLC (Metrex) works to provide value-added infection prevention products and services in global healthcare environments. We offer a complete line of high-quality enzymatic detergents, high-level disinfectants/sterilants, surface disinfectants for use in hospitals, liquid medical waste disposal products, hand hygiene products, eye shields and many other infection prevention products. Our products are specifically designed for healthcare markets such as acute care, primary care, ambulatory surgery centers (ASC), EMS/Fire/Police, extended care, and the public sector.
CONTACT:
Dianne Heckler, [email protected], 435.400.0435
Source: Metrex
Share:
Tags: CaviCide, CaviWipes, Coronavirus, COVID-19, Metrex, MetriCide OPA Plus Solution